Taisho Pharmaceutical Holdings Co., Ltd.

URI: https://gptkb.org/entity/Taisho_Pharmaceutical_Holdings_Co.,_Ltd.
GPTKB entity
Statements (28)
Predicate Object
gptkbp:instanceOf gptkb:public_company
gptkbp:acquiredBy UPSA (from Bristol-Myers Squibb, 2019)
gptkbp:CEO gptkb:Shigeru_Uehara
gptkbp:country gptkb:Japan
gptkbp:founded 1912
gptkbp:founder gptkb:Uehara_family
gptkbp:headquarters_location gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label Taisho Pharmaceutical Holdings Co., Ltd.
gptkbp:industry Pharmaceuticals
Consumer healthcare
gptkbp:ISIN JP3442850008
gptkbp:logo Taisho_Pharmaceutical_logo.svg
gptkbp:notableProduct gptkb:Lipovitan_D
gptkb:Pabron
RiUP
gptkbp:numberOfEmployees 6,400
gptkbp:parentCompany Uehara family (major shareholder)
gptkbp:products Over-the-counter drugs
Prescription pharmaceuticals
gptkbp:revenue JPY 280 billion (approx., 2023)
gptkbp:servesArea Worldwide
gptkbp:stockExchange gptkb:Tokyo_Stock_Exchange
gptkbp:stockSymbol 4581
gptkbp:subsidiary Taisho Pharmaceutical Co., Ltd.
gptkbp:type gptkb:company
gptkbp:website https://www.taisho-holdings.co.jp/en/
gptkbp:bfsParent gptkb:Taisho_Pharmaceutical
gptkbp:bfsLayer 7